DE2148838A1 - Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben - Google Patents

Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Info

Publication number
DE2148838A1
DE2148838A1 DE19712148838 DE2148838A DE2148838A1 DE 2148838 A1 DE2148838 A1 DE 2148838A1 DE 19712148838 DE19712148838 DE 19712148838 DE 2148838 A DE2148838 A DE 2148838A DE 2148838 A1 DE2148838 A1 DE 2148838A1
Authority
DE
Germany
Prior art keywords
general formula
adenosine derivatives
adenosine
straight
branched alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19712148838
Other languages
German (de)
English (en)
Inventor
Erich Dr Fauland
Wolfgang Dr Rer Nat Kampe
Egon Dr Med Roesch
Harald Dr Med Stork
Max Dr Rer Nat Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19712148838 priority Critical patent/DE2148838A1/de
Priority to HUBO1394A priority patent/HU163674B/hu
Priority to GB4381372A priority patent/GB1342706A/en
Priority to AR244242A priority patent/AR193757A1/es
Priority to DD165804A priority patent/DD100717A5/xx
Priority to ES406933A priority patent/ES406933A1/es
Priority to NL7212929A priority patent/NL7212929A/xx
Priority to ZA726558A priority patent/ZA726558B/xx
Priority to CH1416672A priority patent/CH564562A5/xx
Priority to AU47232/72A priority patent/AU462347B2/en
Priority to FR7234353A priority patent/FR2154686B1/fr
Priority to AT840772A priority patent/AT316764B/de
Priority to CA152,966A priority patent/CA965086A/en
Priority to JP9854972A priority patent/JPS5549593B2/ja
Publication of DE2148838A1 publication Critical patent/DE2148838A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712148838 1971-09-30 1971-09-30 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben Withdrawn DE2148838A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE19712148838 DE2148838A1 (de) 1971-09-30 1971-09-30 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
HUBO1394A HU163674B (https=) 1971-09-30 1972-09-21
GB4381372A GB1342706A (en) 1971-09-30 1972-09-21 N-6-disubstituted adenosine derivatives and the preparation thereof
AR244242A AR193757A1 (es) 1971-09-30 1972-09-22 Un procedimiento para la obtencion de derivados de adenosina disubstituidos
DD165804A DD100717A5 (https=) 1971-09-30 1972-09-22
ES406933A ES406933A1 (es) 1971-09-30 1972-09-22 Procedimiento para la preparacion de nuevos derivados de adenosina disustituidos en n (6).
NL7212929A NL7212929A (https=) 1971-09-30 1972-09-25
ZA726558A ZA726558B (en) 1971-09-30 1972-09-26 New n(6)-disubstituted adenosine derivatives and the preparation thereof
CH1416672A CH564562A5 (https=) 1971-09-30 1972-09-27
AU47232/72A AU462347B2 (en) 1971-09-30 1972-09-28 New n(6)-disubstituted adenosine derivatives andthe preparation thereof
FR7234353A FR2154686B1 (https=) 1971-09-30 1972-09-28
AT840772A AT316764B (de) 1971-09-30 1972-09-29 Verfahren zur Herstellung von neuen N(6)-disubstituierten Adenosin-Derivaten
CA152,966A CA965086A (en) 1971-09-30 1972-09-29 N(6)-disubstituted adenosine derivatives and process for their preparation
JP9854972A JPS5549593B2 (https=) 1971-09-30 1972-09-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712148838 DE2148838A1 (de) 1971-09-30 1971-09-30 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Publications (1)

Publication Number Publication Date
DE2148838A1 true DE2148838A1 (de) 1973-04-05

Family

ID=5821069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712148838 Withdrawn DE2148838A1 (de) 1971-09-30 1971-09-30 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Country Status (14)

Country Link
JP (1) JPS5549593B2 (https=)
AR (1) AR193757A1 (https=)
AT (1) AT316764B (https=)
AU (1) AU462347B2 (https=)
CA (1) CA965086A (https=)
CH (1) CH564562A5 (https=)
DD (1) DD100717A5 (https=)
DE (1) DE2148838A1 (https=)
ES (1) ES406933A1 (https=)
FR (1) FR2154686B1 (https=)
GB (1) GB1342706A (https=)
HU (1) HU163674B (https=)
NL (1) NL7212929A (https=)
ZA (1) ZA726558B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032583A (en) * 1987-12-23 1991-07-16 Glaxo Group Limited 2,N-6-disubstituted adenosines and their antihypertensive methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1219205A (fr) * 1954-05-06 1960-05-16 American Cyanamid Co Procédé de préparation des ribofuranosylpurines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032583A (en) * 1987-12-23 1991-07-16 Glaxo Group Limited 2,N-6-disubstituted adenosines and their antihypertensive methods of use

Also Published As

Publication number Publication date
DD100717A5 (https=) 1973-10-05
CA965086A (en) 1975-03-25
GB1342706A (en) 1974-01-03
ES406933A1 (es) 1975-10-01
AT316764B (de) 1974-07-25
CH564562A5 (https=) 1975-07-31
ZA726558B (en) 1973-07-25
JPS5549593B2 (https=) 1980-12-12
AU462347B2 (en) 1975-06-19
NL7212929A (https=) 1973-04-03
HU163674B (https=) 1973-10-27
AR193757A1 (es) 1973-05-22
JPS4861496A (https=) 1973-08-28
FR2154686A1 (https=) 1973-05-11
FR2154686B1 (https=) 1975-10-31
AU4723272A (en) 1974-04-04

Similar Documents

Publication Publication Date Title
DE2407115C3 (de) 2,6-Dimethyl-l,4-dihydropyridin-3carbonsäureamino-alkylesterderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2918261C2 (https=)
DE69216221T2 (de) Verbindungen mit guanidin-struktur und diese enthaltende pharmazeutische zusammensetzungen
DE2136624A1 (de) N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
DE69104948T2 (de) Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE2653257C2 (https=)
DE69031989T2 (de) Selektive Adenosinrezeptor-Liganden
EP1368313A1 (de) Verfahren zur herstellung von nicht hydratisiertem fexofenadin-hydrochlorid und eine so erhaetliche neue kristalline form
DE2253750C3 (de) Apovincaminsaure-alkylester, Verfahren zu ihrer Herstellung und pharmazeutische
DE2528609C3 (de) Desoxyvincaminsäureamide, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und Arzneimittel
DE2148838A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
EP0553385B1 (de) Salicyloyl-carnitin und Verfahren zu seiner Herstellung
DE2930608A1 (de) Alkylthiophenoxyalkylamine, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2157036A1 (de) Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2426682A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2244328A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2651789A1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2521104B2 (de) 4-Aryl-aminoalkyl-4-thiazolin-2-one, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CH629806A5 (en) Process for the preparation of substituted purines
DE2059922A1 (de) Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
DE2238923A1 (de) Acylierte n(6)-aralkyl-adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2601755C2 (de) Pseudoisocytidin und dessen Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE924632C (de) Verfahren zur Herstellung von Dialkylxanthinabkoemmlingen
DE69014256T2 (de) Benzopyran-Derivate.

Legal Events

Date Code Title Description
OD Request for examination
8130 Withdrawal